←Back to Expert Scholars
Translational Medicine / 转化医学ADC Lineage Targets
Sachin Agarwal
PhD
🏢Gilead Sciences🌐USA
Director of Translational Medicine
22
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sachin Agarwal supports translational medicine and biomarker development for TROP2 directed ADCs including sacituzumab govitecan. His work defines lineage expression patterns and resistance mechanisms for TROP2 targeting across breast and urothelial cancers. He integrates correlative science with clinical trials.
Share:
🧪Research Fields 研究领域
antibody drug conjugates
TROP2
sacituzumab govitecan
translational research
biomarkers
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sachin Agarwal 的研究动态
Follow Sachin Agarwal's research updates
留下邮箱，当我们发布与 Sachin Agarwal（Gilead Sciences）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment